Hainan General Kangli Pharmaceutical

Hainan General Kangli Pharmaceutical is a China-based pharmaceutical manufacturing company focused on commercialized chemical generic medicines. It operates as a subsidiary within the China Meheco/Genertec Meheco group and manufactures marketed hospital and anti-infective products rather than a broad innovative biotech pipeline. Public disclosures indicate recent regulatory milestones for tedizolid phosphate for injection and ganciclovir for injection in China, alongside broader capabilities in antibiotic and other chemical drug categories. The company appears to be primarily a commercial-stage pharmaceutical producer serving the Chinese market through the parent group’s integrated manufacturing and distribution network.